Search for Clinical Trial Results

Sponsored By

Multicentric Castleman Disease - 17 Studies Found

Status Study
Active, not recruiting Study Name: A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease
Condition: Multicentric Castleman's Disease
Date: 2011-04-21
Interventions: Drug: Siltuximab Type=exact number, unit=mg/kg, number=11, form=intravenous solution, route=intravenous.
Active, not recruiting Study Name: A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease
Condition: Multicentric Castleman's Disease
Date: 2009-11-30
Interventions:
  • Drug: Siltuximab Siltuximab 11
Recruiting Study Name: TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial
Condition: Multicentric Castleman Disease
Date: 2017-01-31
Interventions: Drug: Thalidomide, cyclophosphamide and prednisone

Withdrawn Study Name: Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
Condition:
  • Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease
  • Drug: Pomalidomide Part A: 5 m
Recruiting Study Name: Tocilizumab for KSHV-Associated Multicentric Castleman Disease
Condition:
  • Castleman Disease
  • Castleman's Disease
  • Giant Lymph Node Hyp
    Date: 2011-09-24
    Interventions:
    • Drug: Zidovudine Zidovudine (A
Withdrawn Study Name: Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
Condition: Giant Lymph Node Hyperplasia
Date: 2006-08-08
Interventions: Drug: Valganciclovir valganciclovir open label, two 450mg tablets orally, twice a day
Terminated Study Name: Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
Condition:
  • HIV Infections
  • Giant Lymph Node Hyperplasia

Date: 2005-08-04
Interventions: Drug: Rituximab
Completed Study Name: A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment
Condition: Castleman's Disease
Date: 2010-08-13
Interventions: Drug: tocilizumab [RoActemra/Actemra] maintenance dose
Recruiting Study Name: Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Condition:
  • Lymphoproliferative Disorder
  • HHV-8
  • Malignancy
  • Date: 2004-09-21
    Interventions:
    • Drug: Etoposide Etoposide 50 m
Recruiting Study Name: Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Condition: